Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension. Mechanism of Action Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Bevantolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Bevantolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Bevantolol. |
| Amifostine | Bevantolol may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Bevantolol. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Bevantolol. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Bevantolol. |
| Obinutuzumab | Bevantolol may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Bevantolol. |
| Rituximab | Bevantolol may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Bevantolol. |
| Zolmitriptan | Zolmitriptan may decrease the antihypertensive activities of Bevantolol. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Bevantolol. |
| Atropine | Atropine may decrease the antihypertensive activities of Bevantolol. |
| Sumatriptan | Sumatriptan may decrease the antihypertensive activities of Bevantolol. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Bevantolol. |
| Naratriptan | Naratriptan may decrease the antihypertensive activities of Bevantolol. |
| Rizatriptan | Rizatriptan may decrease the antihypertensive activities of Bevantolol. |
| Dopamine | Dopamine may decrease the antihypertensive activities of Bevantolol. |
| Frovatriptan | Frovatriptan may decrease the antihypertensive activities of Bevantolol. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Bevantolol. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Bevantolol. |
| Yohimbine | Yohimbine may decrease the antihypertensive activities of Bevantolol. |
| Solifenacin | Solifenacin may decrease the antihypertensive activities of Bevantolol. |
| Epicaptopril | Epicaptopril may decrease the antihypertensive activities of Bevantolol. |
| 1-benzylimidazole | 1-benzylimidazole may decrease the antihypertensive activities of Bevantolol. |
| Amineptine | Amineptine may decrease the antihypertensive activities of Bevantolol. |
| Flibanserin | Flibanserin may decrease the antihypertensive activities of Bevantolol. |
| Naluzotan | Naluzotan may decrease the antihypertensive activities of Bevantolol. |
| Nitrous oxide | Nitrous oxide may decrease the antihypertensive activities of Bevantolol. |
| Cinitapride | Cinitapride may decrease the antihypertensive activities of Bevantolol. |
| Tyramine | Tyramine may decrease the antihypertensive activities of Bevantolol. |
| Ifenprodil | Ifenprodil may decrease the antihypertensive activities of Bevantolol. |
| Dimetacrine | Dimetacrine may decrease the antihypertensive activities of Bevantolol. |
| Butriptyline | Butriptyline may decrease the antihypertensive activities of Bevantolol. |
| Moxisylyte | Moxisylyte may decrease the antihypertensive activities of Bevantolol. |
| Tianeptine | Tianeptine may decrease the antihypertensive activities of Bevantolol. |
| Oxaprotiline | Oxaprotiline may decrease the antihypertensive activities of Bevantolol. |
| Atipamezole | Atipamezole may decrease the antihypertensive activities of Bevantolol. |
| Tetrahydrocannabivarin | Tetrahydrocannabivarin may decrease the antihypertensive activities of Bevantolol. |
| Piclozotan | Piclozotan may decrease the antihypertensive activities of Bevantolol. |
| Siponimod | Siponimod may decrease the antihypertensive activities of Bevantolol. |
| Idazoxan | Idazoxan may decrease the antihypertensive activities of Bevantolol. |
| Tramazoline | Tramazoline may decrease the antihypertensive activities of Bevantolol. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the antihypertensive activities of Bevantolol. |
| Dibenzepin | Dibenzepin may decrease the antihypertensive activities of Bevantolol. |
| Quinupramine | Quinupramine may decrease the antihypertensive activities of Bevantolol. |
| Trichloroethylene | Trichloroethylene may decrease the antihypertensive activities of Bevantolol. |
| Fenozolone | Fenozolone may decrease the antihypertensive activities of Bevantolol. |
| Melitracen | Melitracen may decrease the antihypertensive activities of Bevantolol. |
| Lofepramine | Lofepramine may decrease the antihypertensive activities of Bevantolol. |
| Xenon | Xenon may decrease the antihypertensive activities of Bevantolol. |
| Iprindole | Iprindole may decrease the antihypertensive activities of Bevantolol. |
| Buflomedil | Buflomedil may decrease the antihypertensive activities of Bevantolol. |
| Diethyl ether | Diethyl ether may decrease the antihypertensive activities of Bevantolol. |
| Imipramine oxide | Imipramine oxide may decrease the antihypertensive activities of Bevantolol. |
| Mefenorex | Mefenorex may decrease the antihypertensive activities of Bevantolol. |
| 5-methoxy-N,N-dimethyltryptamine | 5-methoxy-N,N-dimethyltryptamine may decrease the antihypertensive activities of Bevantolol. |
| Quinoline Yellow WS | Quinoline Yellow WS may decrease the antihypertensive activities of Bevantolol. |
| Solriamfetol | Solriamfetol may decrease the antihypertensive activities of Bevantolol. |
| Sufentanil | Sufentanil may decrease the antihypertensive activities of Bevantolol. |
| Isoflurane | Isoflurane may decrease the antihypertensive activities of Bevantolol. |
| Propofol | Propofol may decrease the antihypertensive activities of Bevantolol. |
| Remifentanil | Remifentanil may decrease the antihypertensive activities of Bevantolol. |
| Halothane | Halothane may decrease the antihypertensive activities of Bevantolol. |
| Desflurane | Desflurane may decrease the antihypertensive activities of Bevantolol. |
| Sevoflurane | Sevoflurane may decrease the antihypertensive activities of Bevantolol. |
| Protriptyline | Protriptyline may decrease the antihypertensive activities of Bevantolol. |
| Opipramol | Opipramol may decrease the antihypertensive activities of Bevantolol. |
| Selpercatinib | Selpercatinib may decrease the antihypertensive activities of Bevantolol. |
| Naxitamab | Naxitamab may decrease the antihypertensive activities of Bevantolol. |
| Cannabidiol | The metabolism of Bevantolol can be decreased when combined with Cannabidiol. |
| Amiodarone | The therapeutic efficacy of Bevantolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Bevantolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Bevantolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Bevantolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Bevantolol. |
| Fingolimod | Bevantolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Bevantolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Bevantolol. |
| Methacholine | Bevantolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Bevantolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bevantolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Bevantolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Bevantolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Bevantolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Bevantolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Bevantolol. |
| Rivastigmine | Bevantolol may increase the bradycardic activities of Rivastigmine. |
| Dapoxetine | Dapoxetine may increase the orthostatic hypotensive activities of Bevantolol. |
| Lurasidone | Bevantolol may increase the hypotensive activities of Lurasidone. |
| Mirabegron | The serum concentration of Bevantolol can be increased when it is combined with Mirabegron. |
| Molsidomine | Molsidomine may increase the hypotensive activities of Bevantolol. |
| Insulin argine | Bevantolol may increase the hypoglycemic activities of Insulin argine. |
| Remikiren | Remikiren may increase the hypotensive activities of Bevantolol. |
| Guanadrel | Guanadrel may increase the hypotensive activities of Bevantolol. |
| Carteolol | Carteolol may increase the hypotensive activities of Bevantolol. |
| Bosentan | Bosentan may increase the hypotensive activities of Bevantolol. |
| Candoxatril | Candoxatril may increase the hypotensive activities of Bevantolol. |
| Metyrosine | Metyrosine may increase the hypotensive activities of Bevantolol. |